Trials / Completed
CompletedNCT00911222
Epidemiological EMESIS-Registry
Epidemiologic Registry for the Description of Antiemetic Strategies Under Real-life Conditions.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,035 (actual)
- Sponsor
- iOMEDICO AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registry is to record information on reality of anti-emetic therapies of cancer-patients in Germany. The outcome of this study is the efficacy of anti-emetic therapies dependent on the rate "complete and major control" of nausea and emesis in moderately and highly emetogenic chemotherapies, consisting of platin-derivates (cisplatin, carboplatin and oxaliplatin), anthracyclines and/or cyclophosphamid.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | non-interventional | non-interventional |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-05-01
- Completion
- 2009-08-01
- First posted
- 2009-06-01
- Last updated
- 2014-12-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00911222. Inclusion in this directory is not an endorsement.